FDA Approved: RHOPRESSA — Original Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved Rhopressa (netarsudil) from Alcon as an original NDA, indicated to reduce elevated intraocular pressure in adults with open-angle glaucoma or ocula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• RHOPRESSA (NETARSUDIL)

Snippet

ORIG AP for RHOPRESSA (NETARSUDIL)